Table 2 Comparison of laboratory, electrocardiographic, and echocardiographic parameters between the ST-segment elevation myocardial infarction (STEMI) and control groups
From: Homocysteine is a bystander for ST-segment elevation myocardial infarction: a case-control study
| Â | STEMI | Control | p value |
|---|---|---|---|
White cell count, ×109/L | 11.9 ± 4 | 6.5 ± 2 | < 0.001* |
Homocysteine, μmol/L | 8.4 ± 2.2 | 7.6 ± 1.9 | 0.142a |
C-reactive protein, mg/L | 2.0 ± 3.0 | 0.2 ± 0.1 | < 0.001* |
Low-density lipoprotein, mg/dL | 111.5 ± 38 | 95 ± 27 | 0.062 |
Creatinine, mg/dL | 1.2 ± 0.8 | 0.9 ± 0.2 | 0.004* |
Hemoglobin A1c, % | 6.5 ± 1.6 | 6.1 ± 1.6 | 0.441 |
PR, ms | 171.1 ± 43 | 173.6 ± 48 | 0.853 |
QRS, ms | 94.9 ± 24 | 90.1 ± 12 | 0.273 |
QTc, ms | 441.1 ± 48 | 416.6 ± 21 | 0.044* |
QRS fragmentation, n(%) | 45(80) | 9(53) | 0.055 |
Early repolarization, n(%) | 18(32) | 3(18) | 0.362 |
Left ventricular ejection fraction, % | 54.1 ± 12 | 69.6 ± 6 | < 0.001* |
E/E’ | 12.4 ± 5 | 12.4 ± 7 | 0.989 |